Trial Profile
A Post Authorisation Safety Study (PASS) of Seroquel XL© Conducted in Primary Care in England
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar depression; Bipolar disorders; Manic episodes; Schizophrenia
- Focus Adverse reactions
- 06 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.